GLP-1 Agonist Use in US Bariatric Surgery Patients

JAMA Network

About The Study: In this retrospective cohort study using a nationwide database, among a cohort of U.S. adults undergoing bariatric surgery, approximately 1 in 10 initiated a glucagon-like peptide-1 receptor agonist. Initiation was greater among women, those undergoing sleeve gastrectomy, and individuals with larger body mass index regain than among their counterparts.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.